The role of both EVs and IL-8 is crucial for neutrophil-mediated tumor drug resistance, which is mainly due to the induction of NETs formation and the secretion of pro-tumoral factors, including neutrophil-derived EVs. This evidence concerns the gene CXCL8 and neoplasm.